Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Modest correlation between IVUS and FFR in intermediate lesions assessment

Original title: FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study Reference: Ron Waksman et al. J Am Coll Cardiol 2013. Article in Press

For patients with angiographically assessed intermediate lesions such as stenosis between 40% and 80%, criteria that favor revascularization remains under debate. 

Fractional Flow Reserve (FFR) is considered the gold standard to assess intermediate lesions, and ≤ 0.8 is considered a significative value. Intravascular ultrasound has traditionally used a 4 mm2 cut-off minimum lumen area (MLA) to classify a lesion as severe; however, this cut-off IVUS value has not been proved equivalent to the functional parameter of FFR.

This prospective, multicenter registry designed to determine the correlation between FFR, IVUS and virtual histology (VH) in intermediate lesions included 350 patients (367 intermediate lesions). Whether to perform an angioplasty procedure or not was the operator’s decision.

ROC analysis identified the 3.07 mm2 global MLA cut-off by IVUS as the best threshold to indentify <0.8 FFR lesions (64% sensitivity, 64% specificity). This global MLA cut-off changes according to the vessel’s reference diameter. For vessels < 3.0 mm in diameter, MLA is <2.4 mm2, vessels between 3.0 and 3.5 mm, MLA = <2.7 mm2 and vessels >3.5 mm, MLA = <3.6 mm2. With these optimal MLA cut-offs by IVUS, taking FFR as gold standard, false positives reached 25.7%. A plaque burden of 68.7 ± 11.2% was the only HV variable which correlated with a <0.8 FFR.

Conclusion 

Anatomical measurement by intravascular ultrasound has a moderate correlation with FFR and depends on the reference diameter.

Comment 

The therapeutic decision for an intermediate lesion should be taken, firstly, following clinical criteria, since both techniques present limitations. IVUS may be a better tool to guide the strategy and monitor the final outcome of an angioplasty procedure, rather than to decide whether to perform it or not.

SOLACI.ORG

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...